WSCM
AGN

Wellington Shields Capital Management’s Allergan plc AGN Stock Holding History

Wellington Shields Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,975
Closed -$757K – 308
2018
Q3 		$757K Sell
3,975
-50
-1% -$9.19K 0.12% 162
2018
Q2 		$671K Buy
+4,025
New +$646K 0.11% 176
2017
Q3 		– Sell
-900
Closed -$219K – 339
2017
Q2 		$219K Sell
900
-400
-31% -$94K 0.04% 305
2017
Q1 		$311K Sell
1,300
-1,800
-58% -$419K 0.05% 255
2016
Q4 		$651K Sell
3,100
-150
-5% -$31.1K 0.11% 171
2016
Q3 		$749K Hold
3,250
– – 0.13% 158
2016
Q2 		$751K Buy
+3,250
New +$749K 0.13% 143

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Wellington Shields Capital Management's AGN Position: Q4 2018 in Review

Wellington Shields Capital Management sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 3,975 shares — an estimated $757K sold.

Wellington Shields Capital Management first reported a position in AGN in Q2 2016 and held it in 7 quarters. The position peaked at $757K in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Wellington Shields Capital Management reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Wellington Shields Capital Management sold 3,975 Allergan plc shares in Q4 2018, an estimated $757K.
  • Wellington Shields Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 7 quarters.
  • Wellington Shields Capital Management's Allergan plc position peaked at $757K in Q3 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Wellington Shields Capital Management's 13F filing for Q4 2018, filed 11 Feb 2019.